Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07464977

EMG and Delta Function in Standard RTSA vs Lateralization

Reverse total shoulder arthroplasty (RTSA) is a well-established method to treat patients with irreparable rotator cuff tears and glenohumeral osteoarthritis. The biomechanical principle implies a medialization and distalization of the center of rotation (COR). Deficiencies in internal and external rotation constitute frequently encountered functional problems. Some studies showed reduced activation of the posterior deltoid in EMG measurements, which may explain the inability to compensate these movements. Lateralized prosthetic designs demonstrated increased external rotation through an alteration of the deltoid's lever arm.

The aim of the study is to investigate the impact of lateralization on functional outcome and deltoid EMG activity in comparison to a standard implantation technique.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

60 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Klinik Donaustadt

Vienna, Austria, 1220

About this study

Introduction Reverse total shoulder arthroplasty (RTSA) is a well-established method to treat patients with irreparable rotator cuff tears and glenohumeral osteoarthritis. The biomechanical principle is a medialization and distalization of the center of rotation (COR) to provide a compensatory role for the insufficient rotator cuff. Deficiencies in internal and external shoulder rotation constitute frequently seen functional problems. Some studies showed reduced activation of the posterior deltoid in EMG measurements, which may explain the inability to compensate these movements. Lateralized prosthetic designs implants demonstrated increased external rotation force through an alteration of the deltoid's lever arm.

Material and Methods This study will be conducted as a monocentric randomized, prospective trial. Approximately 130 patients, scheduled for reversed total shoulder arthroplasty (RSA), will be enrolled. The patients will be divided into two groups depending on receiving RSA or a lateralized implant via randomization. Preoperatively and at 4 follow-up visits, a surface EMG (sEMG) of the deltoid muscle will be conducted and clinical scores (Constant-Murley Score and Quick DASH questionnaire) will be assessed. As patient related outcome measures, p-ASES-S and SVV will be evaluated. Pre- and postoperative x-rays and CT scans will be conducted for preoperative planning and measurement of achieved lateralization. Clinical and radiological complications will be routinely documented. Group comparisons and correlations will be performed to compare both groups pre- and postoperatively. The study's duration is scheduled for 2 years.

Aim of the Study The aim of the study is to evaluate a possible difference in function and EMG activity between the two patient groups. Especially a different increase in external rotation range of motion and strength shall be investigated. Furthermore a possible connection between preoperative deltoid muscle activity and postoperative outcome shall be pointed out. Lastly, the impact of lateralization on functional outcome, shall be evaluated compared to the standard implantation technique.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • male/female, 60-85y
  • diagnosis of Cuff tear arthropathy (CTA)
  • irreparable rotator cuff tear
  • severe osteoarthritis (OA)
  • primary RSA
  • verified rotator cuff tear in preoperative MRI
  • absence of severe cognitive impairment

Exclusion criteria

  • previous muscle transfer
  • revision surgery
  • highly dysplastic glenoid
  • axillary nerve palsy
  • upper limb radiculopathy
  • cervical myelopathy
  • degenerative muscular disease,
  • previous proximal humeral fracture
  • revision arthroplasty
  • rheumatoid arthritis

Treatment and study plan

Lateralization of glenoid component

Device

Lateralization of glenoid component in reverse total shoulder arthroplasty via metal augment on the glenoid side with a thickness of at least 4mm

Standard implantation technique

Device

Implantation of a standard glenoid component without any lateralization via metal back on the glenoid site

Primary outcomes

  1. Delta Muscle activity (especially posterior Delta part)

    Time frame: preoperative

    The ratio between peak torque and EMG root mean square is measured

  2. Delta Muscle activity (especially posterior Delta part)

    Time frame: 6 weeks postoperative

    The ratio between peak torque and EMG root mean square is measured

  3. Delta Muscle activity (especially posterior Delta part)

    Time frame: 3 months postoperative

    The ratio between peak torque and EMG root mean square is measured

  4. Delta Muscle activity (especially posterior Delta part)

    Time frame: 6 months postoperative

    The ratio between peak torque and EMG root mean square is measured

  5. Delta Muscle activity (especially posterior Delta part)

    Time frame: 1 year postoperative

    The ratio between peak torque and EMG root mean square is measured

Secondary outcomes

  1. Range of movement (forward flexion, abduction, external rotation, extension)

    Time frame: preoperative

    ROM (range of movement) measured with a goniometer according to neutral zero method

  2. Range of movement (forward flexion, abduction, external rotation, extension)

    Time frame: 6 weeks postoperative

    ROM (range of movement) measured with a goniometer according to neutral zero method

  3. Range of movement (forward flexion, abduction, external rotation, extension)

    Time frame: 3 months postoperative

    ROM (range of movement) measured with a goniometer according to neutral zero method

  4. Range of movement (forward flexion, abduction, external rotation, extension)

    Time frame: 6 months postoperative

    ROM (range of movement) measured with a goniometer according to neutral zero method

  5. Range of movement (forward flexion, abduction, external rotation, extension)

    Time frame: 1 year postoperative

    ROM (range of movement) measured with a goniometer according to neutral zero method

  6. Objective and subjective outcome scores / Quality of life scores

    Time frame: preoperative, 6 weeks postoperative, 3 months postoperative, 6 months postoperative, 12 months postoperative

    Constant score (0-100) (higher = better)

  7. Objective and subjective outcome scores / Quality of life scores

    Time frame: preoperative, 6 weeks postoperative, 3 months postoperative, 6 months postoperative, 12 months postoperative

    SVV (subjective shoulder value) (0-100%) (higher = better)

  8. Objective and subjective outcome scores / Quality of life scores

    Time frame: preoperative, 6 weeks postoperative, 3 months postoperative, 6 months postoperative, 12 months postoperative

    p-ASES (patient-reported American Shoulder and Elbow Surgeons Score) (0-100) (higher = better)

  9. Objective and subjective outcome scores / Quality of life scores

    Time frame: preoperative, 6 weeks postoperative, 3 months postoperative, 6 months postoperative, 12 months postoperative

    Quick-DASH (Quick-Disability of Arm, Shoulder and Hand) (0-100) (higher = better)

  10. Difference in lateralization between preoperative 3D CT-based planning and postoperative CT-based implant position

    Time frame: Preoperative and 1 year postoperative

    Lateralization will be quantitatively assessed by comparing preoperative and postoperative computed tomography (CT) scans. The preoperative CT scan will be used for 3D planning and virtual implantation. The postoperative CT scan will be used to determine the actually achieved implant position.

    The original preoperative joint line will serve as the reference value. Medialization or lateralization will be measured as the linear distance (in millimeters) between the preoperative joint line and the postoperative implant position. The achieved lateralization will be calculated based on this difference.

    Additionally, the planned lateralization from the preoperative 3D virtual implantation will be compared with the actually achieved lateralization measured on the postoperative CT scan. The primary metric will be the absolute and mean deviation (in millimeters) between planned and achieved lateralization, allowing assessment of the accuracy of the preoperative 3D planning.

  11. Humeral Length (Millimeters) Measured on Standardized Radiographs

    Time frame: preoperative, 6 weeks postoperative, 3 months postoperative, 6 months postoperative, 12 months postoperative

    Humeral length will be measured in millimeters on standardized anteroposterior radiographs of the entire humerus obtained according to the Lädermann protocol. Measurements will be performed by comparing preoperative and postoperative radiographs. The primary metric will be the absolute difference in humeral length between preoperative and postoperative images. Measurements will be performed using calibrated digital imaging software by blinded reviewers.

Study contacts

Contact information is provided by the study sponsor or research team.

Robert Breuer, MD

CONTACT

[email protected]

00430128802 ext. 743429

Valentin Pichler, MD

CONTACT

[email protected]

00430128802 ext. 743400

Sponsors and collaborators

Lead sponsor

Vienna Hospital Association

Other Gov

Registry information

Official study title

Postoperative Deltoid EMG Activity and Function in Patients After Reverse Total Shoulder Arthroplasty: A Comparison of Standard Implantation Technique and Lateralization

Acronym: EMGRTSA

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Mar 11, 2026
Registry last updated
May 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.